Capricorn Fund Managers’s Avidity Biosciences RNAM Stock Holding History

Capricorn Fund Managers’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-68,463	Closed	-$4.94M	–	138
2025 Q4	$4.94M	Buy	68,463 +57,663	+534%	+$3.72M	1.19%	32
2025 Q3	$471K	Buy	+10,800	New	+$437K	0.16%	58

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Capricorn Fund Managers's RNAM Position: Q1 2026 in Review

Capricorn Fund Managers sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 68,463 shares — an estimated $4.94M sold.

Capricorn Fund Managers first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $4.94M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Capricorn Fund Managers reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Capricorn Fund Managers sold 68,463 Avidity Biosciences shares in Q1 2026, an estimated $4.94M.
Capricorn Fund Managers first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Capricorn Fund Managers's Avidity Biosciences position peaked at $4.94M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Capricorn Fund Managers's 13F filing for Q1 2026, filed 24 Apr 2026.